Analysis of PD-L1 Transcriptional Activity by Chromatin Immunoprecipitation

Suprataptha U Reddy1, Riddhi Mehta1, Ivana Vancurova2

  • 1Department of Biological Sciences, St. John's University, Queens, NY, USA.

Insights

Programmed death-ligand 1 (PD-L1) nuclear accumulation in ovarian cancer cells drives interleukin-8 (IL-8) transcription. This PD-L1 recruitment to the IL-8 promoter enhances cancer progression and invasion.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cancer Research

Background:

  • Programmed death-ligand 1 (PD-L1) is known as a cell surface protein but also functions in the nucleus.
  • Interleukin-8 (IL-8) is a chemokine that promotes cancer progression, proliferation, and invasion.
  • Understanding PD-L1's role in IL-8 regulation is crucial for improving immunotherapies.

Purpose of the Study:

  • To describe a protocol for quantifying PD-L1 recruitment to the IL-8 promoter.
  • To investigate the role of PD-L1 in the transcriptional regulation of IL-8 in ovarian cancer cells.

Main Methods:

  • Chromatin immunoprecipitation (ChIP) was used to analyze PD-L1 recruitment to the IL-8 promoter.
  • Quantitative real-time PCR (qPCR) was employed with specific primers for the IL-8 promoter.
  • An antibody recognizing endogenous PD-L1 was utilized for ChIP analysis.

Main Results:

  • IFNγ significantly increases PD-L1 recruitment to the transcription start site (TSS) of the IL-8 promoter.
  • PD-L1 recruitment was even higher to a region ~500 bp upstream of the TSS, containing transcription factor binding sites.
  • Results suggest PD-L1 associates with the IL-8 promoter by binding to other transcription factors.

Conclusions:

  • PD-L1 plays a significant role in the transcriptional regulation of IL-8 in ovarian cancer cells.
  • IFNγ-induced nuclear PD-L1 accumulation enhances IL-8 transcription via promoter recruitment.
  • This mechanism highlights a novel target for enhancing PD-L1-based immunotherapies.